AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.
About
PathAI develops AI-powered pathology solutions to improve patient outcomes and advance drug and diagnostic development. Their core offerings include the AISight® Digital Pathology Platform, an enterprise workflow solution for image and case management, and AI product solutions for biomarker quantification and workflow optimization. PathAI serves biopharma companies, academic medical centers, reference laboratories, and health systems.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
58Traction
40Team
60Visibility
0Profile
0Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does PathAI do?
PathAI develops AI-powered pathology solutions to improve patient outcomes and advance drug and diagnostic development. Their core offerings include the AISight® Digital Pathology Platform, an enterprise workflow solution for image and case management, and AI product solutions for biomarker quantification and workflow optimization. PathAI serves biopharma companies, academic medical centers, reference laboratories, and health systems.
How much funding has PathAI raised?
PathAI has raised a total of $165M in funding. The most recent round on record is Series C.
Where is PathAI headquartered?
PathAI is headquartered in Boston, United States.
When was PathAI founded?
PathAI was founded in 2016.
What industry does PathAI operate in?
PathAI operates in AI, Healthcare, Biotech, SaaS, Healthcare AI.